Vivanza Biosciences Ltd share price logo

Vivanza Biosciences Ltd (530057)

₹4.950.41%

bell
Get free price alerts. Set up your Free investment account to get Live Prices.
Overview
News
Financials
Q1 2024 Results
Technicals

Performance

  • Day's Low

    Day's High

    ₹4.84
    ₹5.02
  • 52 Week's Low

    52 Week's High

    ₹4.68
    ₹14.74
1 Month Return-12.43 %
3 Month Return-39.51 %
1 Year Return-66.55 %
Previous Close₹4.93
Open₹5.02
Volume83.52K
Upper Circuit-
Lower Circuit-
Market Cap₹19.72Cr

Key Statistics

P/E Ratio35.21
PEG Ratio157.21
Market Cap₹19.72 Cr
P/B Ratio5.75
EPS0

Company Information

Ivee Injectaa, a public limited company incorporated in March 1982 is engaged in large-volume parenteral drug manufacturing with an installed capacity of 18 lac pa in Sabalpur, Gujarat. Recently, it has completed an expansion and diversification program to increase the production to 54 lac pa with an additional small-volume parenteral manufacturing capacity of 294 lac pa. To fund the expansion, a public issue of 2170000 equity shares of Rs 10 each was released, aggregating Rs 217 lac. As one of the few companies with facilities for both glass and plastic containers, Ivee Injectaa was awarded a rate contract from the Government of Gujarat to supply its products for one year. Amidst the difficult business conditions in 19992000 due to recessionary trends, the company continues to strive for overall improvement in working.

Share Price: ₹4.95 per share as on 24 Jul, 2024 04:01 PM
Market Capitalisation: ₹19.72Cr as of today
Revenue: ₹4.42Cr as on March 2024 (Q1 24)
Net Profit: ₹0.41Cr as on March 2024 (Q1 24)
Listing date: 01 Jan, 0001
OrganisationVivanza Biosciences Ltd
Headquarters
IndustryTrading
E-voting on sharesClick here to vote

Key events for Vivanza Biosciences Ltd

  • Vivanza Biosciences Q4 Results Show Decrease in Revenue and Increase in Loss - 03 May, 2024

    Vivanza Biosciences reported a 46.32% YoY decrease in topline, with revenue declining by 32.6% QoQ. The loss increased by 309.27% YoY and 305.83% QoQ. Operating income decreased by 3344.44% YoY and 153.39% QoQ. EPS for Q4 was ₹-0.1, down by 285.65% YoY.

Insights on Vivanza Biosciences Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 56.76% to 59.95% in Jun 2024 quarter

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 43.24% to 40.05% in Jun 2024 quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 4 quarters, 0.49 Cr → -0.41 Cr (in ₹), with an average decrease of 120.5% per quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 4 quarters, 9.24 Cr → 4.39 Cr (in ₹), with an average decrease of 21.5% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, Vivanza Biosci. stock has moved down by -12.4%

Company Financials

Value in ₹ crore
Q'1 24Q/Q Change
Revenue
₹4.42Cr
↓32.62%
Net Income
-₹0.41Cr
↓295.24%
Net Profit Margin
-9.28%
↓390.00%
2024Y/Y Change
Revenue
₹27.84Cr
↑56.32%
Net Income
₹0.55Cr
↓8.33%
Net Profit Margin
1.98%
↓41.25%
Value in ₹ crore
2024Y/Y Change
Total Assets
₹16.86Cr
↓17.47%
Total Liabilities
₹12.14Cr
↓24.27%
Value in ₹ crore
2024Y/Y Change
Operating Cash Flow
₹1.78Cr
↑1,012.50%

Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
40.05%
-7.39
Foreign Institutions
0%
0.00
Mutual Funds
0%
0.00
Retail Investors
59.95%
5.63
Others
0%
0.00

Key Indicators

Vivanza Biosciences Ltd Valuation

Vivanza Biosciences Ltd in the last 5 years

  • Overview

  • Trends

Lowest (-15423.93x)

December 21, 2022

Today (35.21x)

July 23, 2024

Industry (102.57x)

July 23, 2024

Highest (884.71x)

July 19, 2023

LowHigh

Earnings and Dividends

  • Vivanza Biosciences Ltd Earnings Results

    Vivanza Biosciences Ltd’s net profit fell -310% since last year same period to ₹0.41Cr in the Q4 2023-2024. On a quarterly growth basis, Vivanza Biosciences Ltd has generated -295.24% fall in its net profits since last 3-months.

    Read More about Earnings Results

Technicals Summary

Bearish

Neutral

Bullish

Bearish

Vivanza Biosciences Ltd is currently in a Bearish trading position according to technical analysis indicators.

Frequently Asked Questions

  • Get a PAN card.
  • Open a Demat account.
  • Open a Trading account.
  • Link your Demat account to your Trading account.
  • Fund your Trading account.
  • Place an order to buy Vivanza Biosciences Ltd shares.

Vivanza Biosciences Ltd (530057) share price today is ₹4.95

Vivanza Biosciences Ltd is not listed on NSE

Vivanza Biosciences Ltd is listed on BSE

  • Today’s highest price of Vivanza Biosciences Ltd is ₹5.02.
  • Today’s lowest price of Vivanza Biosciences Ltd is ₹4.84.

PE Ratio of Vivanza Biosciences Ltd is 35.21

PE ratio = Vivanza Biosciences Ltd Market price per share / Vivanza Biosciences Ltd Earnings per share

Today’s traded volume of Vivanza Biosciences Ltd(530057) is 83.52K.

Today’s market capitalisation of Vivanza Biosciences Ltd(530057) is ₹19.72Cr.

Vivanza Biosciences Ltd(530057Price
52 Week High
₹14.74
52 Week Low
₹4.68

Vivanza Biosciences Ltd(530057) share price is ₹4.95. It is down -66.42% from its 52 Week High price of ₹14.74

Vivanza Biosciences Ltd(530057) share price is ₹4.95. It is up 5.77% from its 52 Week Low price of ₹4.68

Vivanza Biosciences Ltd(530057Returns
1 Day Returns
0.02%
1 Month Returns
-12.43%
3 Month Returns
-39.51%
1 Year Returns
-66.55%